The present invention relates to compounds of Formula (I),
or a form thereof, wherein ring A, R
1
, L and R
2
are as defined herein, useful as FLAP modulators. The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.
Compounds of formula (I):
wherein R
1
, R
2
, R
3
, R
5
, R
6
, A
1
, A
2
, A
3
, A
4
assume meanings as defined in formula (I) are inhibitors of neutrophil elastase.